packageTreosulfan

treosulfan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Treosulfan is an alkylating anticancer drug used as conditioning treatment before hematopoietic stem cell transplantation. It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q7838652 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:treosulfan
ATC codes:L01AB02
DrugBank:DB11678
PubChem CID:9882105
ChEBI:82557
Wikidata:Q7838652
formula:C6H14O8S2
molar mass:278.29 g/mol (PubChem CID 9882105)
logP:-2.2 (Drugs.Common 25.09, not verified)

Metabolites

EBDMEBDMmolar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
EBDMmetabolite: EBDM